Please login to the form below

Not currently logged in
Email:
Password:

Kaletra

This page shows the latest Kaletra news and features for those working in and with pharma, biotech and healthcare.

WHO to test three more potential COVID-19 treatments

WHO to test three more potential COVID-19 treatments

Hydroxychloroquine and lopinavir/ritonavir (AbbVie’s Kaletra) are not being used currently, while UK-based biotech Synairgen has an ongoing trial investigating an inhaled formulation of Interferon-beta-1a in

Latest news

More from news
Approximately 3 fully matching, plus 28 partially matching documents found.

Latest Intelligence

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    19. Kaletra combines two antivirals, lopinavir and ritonavir, and is already approved for use as a treatment for HIV. ... who].were late in infection and already had considerable tissue damage”. However, the study also found that Kaletra is unable to

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....